Talk:Missed dose

Discussion page·2 threads·no archives

This is the discussion page for the article Missed dose. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.

Not a substitute for labellingResolved

This is a topic where readers will want a rule. The article gives reasoning and points at product labelling instead, which is the only defensible position. — MissedDoseMik (talk) 09:40, 27 February 2026 (UTC)

And it says explicitly that the windows differ between products because the half-lives do. That is the reason a general rule cannot exist. ✓ Done — LabelLibby (talk) 13:15, 27 February 2026 (UTC)

Resolved. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.

Doubling a doseDone

Worth stating plainly that no labelling in this class directs dose doubling and that the pharmacokinetics argue against it. People do ask. — SafetySignalSid (talk) 10:20, 1 May 2026 (UTC)

Stated as a fact about the labelling plus a mechanistic reason, rather than as advice. ✓ Done — TitrationTheo (talk) 14:05, 1 May 2026 (UTC)

Done. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.

This page was last edited on 1 May 2026, by TitrationTheo. Text is available under the PeptidePedia Wiki Content Licence (PPCL-BY-SA 4.0).